ALIX |
Apoptosis-linked gene 2-interacting protein X |
APC |
Antigen-presenting cell |
AR |
Androgen receptor |
AR-V7 |
Androgen receptor splice variant 7 |
ASC |
Adipose-derived stromal cell |
Bcl-xL |
B-cell lymphoma-extra large |
BPH |
Benign prostatic hyperplasia |
cfDNA |
Cell-free DNA |
CRPC |
Castration-resistant prostate cancer |
CTC |
Circulating tumor cell |
DNA |
Deoxyribonucleic acid |
DRE |
Digital rectal exam |
ESCRT |
Endosomal sorting complexes required for transport |
ESE |
Early sorting endosome |
EMT |
Epithelial–mesenchymal transition |
EV |
Extracellular vesicle |
FABP5 |
Fatty acid-binding protein 5 |
FasL |
Fas ligand |
HSP |
Heat shock protein |
ICAM-1 |
Intercellular adhesion molecule 1 |
ILV |
Intraluminal vesicle |
iRGD |
Internal arginylglycylaspartic acid |
KLK |
Kallikrein |
LSE |
Late sorting endosome |
mCRPC |
Metastatic castration-resistant prostate cancer |
MET |
Mesenchymal–epithelial transition |
mRNA |
Messenger RNA |
MHC-II |
Major histocompatibility complex class II |
MVB |
Multivesicular body |
ncRNA |
Noncoding RNA |
NTA |
Nanoparticle tracking analysis |
PCA3 |
Prostate cancer antigen 3 |
PCPT |
Prostate cancer prevention trial |
PSA |
Prostate-specific antigen |
PSMA |
Prostate-specific membrane antigen |
RCC |
Renal cell carcinoma |
RNA |
Ribonucleic acid |
SEC |
Size-exclusion chromatography |
siRNA |
Small interfering RNA |
TMPRSS2:ERG |
Transmembrane protease serine 2:ETS (erythroblast transformation-specific)-related gene |
UC |
Ultracentrifugation |